RSS-Feed abonnieren

DOI: 10.1055/s-0045-1805084
Parvovirus B19 Infection Mimicking Autoimmune Hepatitis: A Brief Report
Funding None.

Abstract
Background Parvovirus B19 can cause a variety of manifestations, mainly in children but occasionally in adults. Parvovirus hepatitis is an uncommon manifestation and is usually mild and self-limited. Parvovirus-related acute severe hepatitis and fulminant hepatitis, including acute liver failure, are rare presentations and can mimic other common causes of hepatitis. We hereby report a case of parvovirus-related severe hepatitis in adolescent girls.
Case Report A 17-year-old girl presented with fever and upper respiratory symptoms, followed by onset of jaundice. Her general and systemic physical examinations were unremarkable except for pallor and icterus. On evaluation, she had severe anemia and hepatocellular pattern of jaundice (the maximum value of total bilirubin was 53, and aspartate and alanine transaminase were 756 and 256, respectively). The etiological workup revealed negative markers for typical viral hepatitis. Still, the autoimmune profile revealed a positive antinuclear antibody, and her liver biopsy was also consistent with autoimmune hepatitis. Because of severe anemia and the absence of other hepatic decompensation, systemic viral illness with hepatic involvement was considered, and workup in the same line revealed parvovirus serology positivity. A final diagnosis of parvovirus-related acute severe hepatitis with aplastic crisis was considered, and she was managed with a short course of oral steroids. She responded well to treatment; clinical and biochemical parameters showed improvement on subsequent follow-up. Even after a prolonged follow-up of 1.5 years, she is in clinical and biochemical remission, further confirming the diagnosis of parvovirus-related acute hepatitis.
Conclusion Parvovirus can cause severe hepatitis and should be considered in the differential diagnosis of hepatitis of unknown etiology, especially if there is concomitant hematological involvement.
Guarantor of Article
Dr. Chhagan Lal Birda.
Consent
An informed consent was obtained for the publication.
Permission to Reproduce Material from Other Sources
Not required.
Ethical Approval and Informed Consent
Ethical approval was obtained from the institutional Ethics Boards. A written informed consent was obtained from the patient.
Authors' contributions
C.L.B., A.A., D.A., P.K., and J.G. contributed to the conception and design of the study. K.M., S.K.S., and C.L.B. were responsible for the generation, collection, assembly, analysis, and interpretation of data. The manuscript was drafted or revised by C.L.B., A.A., D.A., P.K., and J.G., while C.L.B. and A.A. conducted a critical revision for important intellectual content. All authors approved the final version of the manuscript.
Publikationsverlauf
Eingereicht: 17. Oktober 2024
Angenommen: 02. Februar 2025
Artikel online veröffentlicht:
24. März 2025
© 2025. Gastroinstestinal Infection Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Bihari C, Rastogi A, Saxena P. et al. Parvovirus b19 associated hepatitis. Hepat Res Treat 2013; 2013: 472027
- 2 Khan U, Uzair Ahmad R, Ullah Z, Fida T, Shehryar M. Parvovirus b19-induced acute hepatitis with hepatosplenomegaly and polyarthropathy. Cureus 2022; 14 (01) e21494
- 3 Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350 (06) 586-597
- 4 Mihály I, Trethon A, Arányi Z. et al. Observations on human parvovirus B19 infection diagnosed in 2011. Orvosi Hetilap 2012; 153 (49) 1948-57
- 5 Furukawa M, Kaji K, Masuda H. et al. Severe aplastic anemia following parvovirus B19-associated acute hepatitis. Case Reports Hepatol 2017; 2017: 1359486
- 6 Díaz F, Collazos J. Hepatic dysfunction due to parvovirus B19 infection. J Infect Chemother 2000; 6 (01) 63-64
- 7 Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A. Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol 2011; 49 (09) 3422-3424
- 8 Osugi Y, Yagasaki H, Sako M. et al; Japan Childhood Aplastic Anemia Study Group. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 2007; 92 (12) 1687-1690
- 9 Singh DP, Agarwal S, Singh R, Nandan D, Gupta A. Therapeutic plasma exchange in parvovirus B19-induced acute hepatic failure. Indian J Crit Care Med 2020; 24 (05) 361-362